Watchlist

Watchlist
Acorda Therapeutics, Inc. (ACOR)
Acorda Therapeutics, Inc. (ACOR)
SHAREHOLDER REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Class Action Lawsuit Filed against Acorda Therapeutics, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP reminds Acorda Therapeutics, Inc. (NASDAQ: ACOR) (Acorda or the Company) shareholders that a class action lawsuit has been filed on behalf of purchasers of the Companys securities between April 1…
Your Daily Pharma Scoop: Roche Highlights Pipeline, GenSight Gets Nod To Start Trial, Bluebird Presents At JPM
Analysis of top Seeking Alpha coverage: Roche Today we will focus on Roche ( OTCQX:RHHBY ), which is one of our favorite companies in the large cap biopharma space. The Swiss drugmaker had a solid 2017, gaining more than 10%. While this is below the performance of the IBB for 2017 (up 21…
FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders of Approaching Deadline in Class Action Lawsuit and Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Acorda Therapeutics, Inc. to Contact the Firm
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Acorda Therapeutics, Inc. (Nasdaq: ACOR) (Acor…
Acorda Announces 2017 AMPYRA Net Sales and Provides 2018 Financial Guidance at J.P. Morgan Healthcare Conference
AMPYRA 4Q 2017 Net Sales of $166 million; 2017 Net Sales of $542 million (unaudited) 2017 year-end cash and cash equivalents approximately $300 million(unaudited) AMPYRA 2018 net sales guidance of $330-$350 million Combined 2018 R&D and SG&A non-GAAP operating exp…
Stocks to watch next week
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. More news on: Apple Inc., Amazon.com, Inc., Intel Corporation, Tech stocks news, …
ACORDA THERAPEUTICS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Acorda Therapeutics, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Acorda Therapeutics, Inc. (Acorda or the Company) (NASDAQ:ACOR) of the January 16, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that…
Acorda up 12% on potential sale
The WSJ reports that Acorda Therapeutics ( ACOR +11.9% ) is exploring a potential sale. The company has been facing generic competition for top seller Ampyra (dalfampridine) since the USPTO invalidated several key patents earlier this year. In Q3, the MS med accounted for almost 99% of i…
Kessler Topaz Meltzer & Check, LLP Announces Shareholder Lawsuit Filed against Acorda Therapeutics, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed against Acorda Therapeutics, Inc. (NASDAQ: ACOR) (Acorda or the Company) on behalf of purchasers of the Companys securities betwee…
Acorda Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
Acorda Therapeutics, Inc. (Nasdaq:ACOR) announced that Ron Cohen, M.D., Acorda's President and CEO, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 10, 2018 at 9:30am PST / 12:30pm EST. A live audio webcast of the presentation can …
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acorda Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline
Pomerantz LLP announces that a class action lawsuit has been filed against Acorda Therapeutics, Inc. (Acorda or the Company) (NASDAQ: ACOR) and certain of its officers. The class action, filed in United States District Court, for the Southern District of New Y…
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Acorda Therapeutics, Inc. - ACOR
NEW YORK , Dec. 22, 2017 /PRNewswire/ --Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Acorda Therapeutics, Inc. (NASDAQ: ACOR) from April 18, 2016 through November 14, 2017 , inclusiv…
Acorda Therapeutics, Inc. (ACOR)